Monday, May 20, 2019

Down Syndrome Screening Evolution


DS screening in pregnancy uk MRCOG tog 2019

TOG Article: Evolution in screening for Down syndrome
Volume 21, Issue 1 January 2019

This article discusses different methods evolved over time for screening of Down Syndrome with some details for latest cell-free DNA testing.


To download original article (free access): Evolution DS Screening

Introduction 
  • The most common reason for invasive testing is to diagnose chromosomal aneuploidies
  • Only done for high risk pregnancies as there is associated risk of miscarriage
  • Down’s syndrome (DS) is the result of an extra chromosome 21
  • Critical factors in screening test are detection rate and false positive rates (FPR)
    • Detection rate: ability of a test to give a positive result for those who have the disease
    • Screen-positive rate: proportion of affected and unaffected persons having a positive result
    • FPR: unaffected proportion yielding a positive result
Screening by maternal age
  • Screening for DS introduced in 1970s.
  • Women aged 40 years or more considered high risk, but it was not possible to offer diagnostic tests to entire population